These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16608908)

  • 1. Sex difference in the antiplatelet effect of aspirin in patients with stroke.
    Cavallari LH; Helgason CM; Brace LD; Viana MA; Nutescu EA
    Ann Pharmacother; 2006 May; 40(5):812-7. PubMed ID: 16608908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin non-responders in Thai ischemic stroke/TIA patients.
    Dharmasaroja P
    J Med Assoc Thai; 2008 Jun; 91(6):818-21. PubMed ID: 18697379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study: baseline characteristics of the population.
    Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox K; Hennerici M; Mattle HP; Rothwell PM;
    Cerebrovasc Dis; 2009; 27(6):608-13. PubMed ID: 19407444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
    Kirshner HS
    Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical inquiries. What is the best management for patients who have a TIA while on aspirin therapy?
    Ahmed N; Coffey JB; Oh R
    J Fam Pract; 2006 Jul; 55(7):627-8. PubMed ID: 16822451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
    Hankey GJ
    Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
    Diener HC
    Int J Stroke; 2006 Feb; 1(1):4-8. PubMed ID: 18706062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP; Saseen JJ
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
    Biller J
    J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced ex vivo inhibition of platelet function following addition of dipyridamole to aspirin after transient ischaemic attack or ischaemic stroke: first results from the TRinity AntiPlatelet responsiveness (TrAP) study.
    Tobin WO; Kinsella JA; Collins DR; Coughlan T; O'Neill D; Egan B; Tierney S; Feeley TM; Murphy RP; McCabe DJ
    Br J Haematol; 2011 Mar; 152(5):640-7. PubMed ID: 21223254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MATCH results: implications for the internist.
    Lutsep HL
    Am J Med; 2006 Jun; 119(6):526.e1-7. PubMed ID: 16750967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin nonresponse in patients with arterial causes of ischemic stroke: considerations in detection and management.
    Biller J
    J Neurol Sci; 2008 Sep; 272(1-2):1-7. PubMed ID: 18534625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical prevention of stroke and stroke recurrence in patients with TIA and minor stroke.
    Weber R; Weimar C; Diener HC
    Expert Opin Pharmacother; 2009 Aug; 10(12):1883-94. PubMed ID: 19558342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Factors associated to aspirin failure for secondary stroke prevention].
    Chamorro A; Blanc R; Ascaso C; Saiz A; Vila N
    Med Clin (Barc); 1997 Nov; 109(15):569-72. PubMed ID: 9441190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability in platelet response to a single daily dose of 150 mg enteric coated aspirin in a high risk population.
    Mardikar H; Deo D; Deshpande N; Mardikar M; Ghosh A; Munot K; Steinhubl S; Mukherjee D
    J Assoc Physicians India; 2008 May; 56():321-4. PubMed ID: 18700638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet and anticoagulant therapy in patients with giant cell arteritis.
    Lee MS; Smith SD; Galor A; Hoffman GS
    Arthritis Rheum; 2006 Oct; 54(10):3306-9. PubMed ID: 17009265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin vs anticoagulation in carotid artery dissection: a study of 298 patients.
    Georgiadis D; Arnold M; von Buedingen HC; Valko P; Sarikaya H; Rousson V; Mattle HP; Bousser MG; Baumgartner RW
    Neurology; 2009 May; 72(21):1810-5. PubMed ID: 19321846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network meta-analysis: simultaneous meta-analysis of common antiplatelet regimens after transient ischaemic attack or stroke.
    Thijs V; Lemmens R; Fieuws S
    Eur Heart J; 2008 May; 29(9):1086-92. PubMed ID: 18349026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma triglycerides as predictors of platelet responsiveness to aspirin in patients after first ischemic stroke.
    Karepov V; Tolpina G; Kuliczkowski W; Serebruany V
    Cerebrovasc Dis; 2008; 26(3):272-6. PubMed ID: 18648200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.